Takeda Pharmaceutical Co Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Takeda Pharmaceutical Company Limited, dated May 14, 2025, reports on share repurchase activities for the period from April 1, 2025, to April 30, 2025. The report details the execution of a share buyback program approved by the Board of Directors on January 30, 2025, which was scheduled to run from February 17, 2025, to May 31, 2025.
Key Financial Metrics
The filing focuses exclusively on capital allocation via share repurchases and does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity.
- Total Repurchase Authorization: 28,500,000 shares with a total budget of JPY 100,000,000,000.
- Repurchases in Reporting Month (April 2025): 11,823,500 shares for a total cost of JPY 49,977,956,800.
- Aggregate Repurchases as of April 30, 2025: 23,367,100 shares for a total cost of JPY 99,955,865,500.
- Program Progress: 81.99% of authorized shares and 99.96% of the authorized budget have been utilized.
- Treasury Shares Disposed: 12,100 shares were disposed of in April 2025 (primarily for stock option exercises) totaling JPY 45,072,500.
- Treasury Shares Held (as of April 30, 2025): 23,558,061 shares.
- Total Issued Shares: 1,590,961,709 shares.
Material Changes and Program Status
The most significant development is the near-completion of the current share repurchase program. The acquisition of shares under the January 30, 2025 resolution was completed on April 23, 2025, based on settlement dates. The company has utilized 99.96% of the JPY 100 billion budget allocated for this specific program.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or risk factors. It is a statutory disclosure of share repurchase execution under Article 24-6 of the Financial Instruments and Exchange Act of Japan. The filing notes that the repurchase method was open-market acquisition through a trust bank.
Key Facts for Investor Verification
- Verify the completion status of the JPY 100 billion share repurchase program, which is 99.96% funded as of April 30, 2025.
- Confirm the average repurchase price in April 2025, which ranged approximately between JPY 4,200 and JPY 4,300 per share based on daily transaction data.
- Note that the company holds 23,558,061 treasury shares as of the end of the reporting period.
- Check for any new Board resolutions regarding future capital return programs, as the current authorization period extends to May 31, 2025, but the budget is effectively exhausted.